Author Archives: Fredricko
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Tuesday, November 10, 2020
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5, 2020
Genmab and ADC Therapeutics Announce Amended Agreement for Camidanlumab Tesirine (Cami)
Innovation Pharmaceuticals and George Mason University Announce Public Release of Laboratory Testing Results Demonstrating Brilacidin’s COVID-19…
Novan Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Trevena, Inc. Announces DEA Scheduling of OLINVYK™ (oliceridine) injection
See original here:
Trevena, Inc. Announces DEA Scheduling of OLINVYK™ (oliceridine) injection
Chiasma Reinforces Commitment to People with Acromegaly and Advocacy Organizations on Acromegaly Awareness Day
Chi-Med to Attend Upcoming Industry and Investor Virtual Conferences
Jounce Therapeutics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Friday, November 6, 2020
BioVie Interview to Air on Bloomberg International on the RedChip Money Report
Aligos Therapeutics Doses First Subject in Phase 1 Proof-of-Concept Study of Small Molecule Drug Candidate ALG-000184 for Chronic Hepatitis B
MHRA Grants HAE Patients Early Access to BioCryst’s Berotralstat in United Kingdom
Go here to see the original:
MHRA Grants HAE Patients Early Access to BioCryst’s Berotralstat in United Kingdom
Nobilis Therapeutics to Present at CapCon 2020 Venture Conference
Generex Subsidiary NuGenerex Immuno-Oncology Announces Appointment of Dr. Tamera Coyne-Beasley to the Scientific Advisory Board for its COVID-19…
BioFlorida Names AIM ImmunoTech CEO Thomas K. Equels as Entrepreneur of the Year
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the Efficacy of OLX10010 in Phase 2a Clinical Trial for Hypertrophic Scars
Medexus Announces Engagement of Westmount Capital and Equity Incentive Grants to Insiders
Read the original here:
Medexus Announces Engagement of Westmount Capital and Equity Incentive Grants to Insiders
CymaBay Therapeutics to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020
Go here to see the original:
CymaBay Therapeutics to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020